PPB STRENGTHENS RISK AND CRISIS MANAGEMENT TO SAFEGUARD PUBLIC HEALTH

Nairobi, Kenya – Strengthening institutional preparedness, accountability and proactive risk management is essential to safeguarding public health and maintaining confidence in the regulation of medicines and health technologies.
This was emphasised by Pharmacy and Poisons Board (PPB) Chairperson, Dr John Munyu, MBS, on 16 November 2026 during a Risk and Crisis Management Workshop attended by Board Members, senior management, staff, representatives from the Gates Foundation and facilitators from PENAM.
Dr Munyu underscored the Board’s responsibility to anticipate, identify and mitigate risks before they escalate, noting that effective risk management must be integrated into all regulatory and operational decisions, including licensing, inspections, pharmacovigilance, procurement and digital transformation.
He identified substandard and falsified medicines, operational and financial challenges, legal exposure, cybersecurity threats and reputational risks as key areas requiring continuous monitoring and coordinated action.
The Chairperson called for clear documentation, assessment and ownership of institutional risks, reaffirming that PPB will not compromise the quality and safety of medical products.
He further emphasised the importance of strong leadership, transparency, timely communication and collective accountability in strengthening institutional resilience, managing crises effectively and sustaining public trust.
Ends